Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Alcohol-associated liver disease: Epidemiology and management
Helena Hernández-Évole; Natalia Jiménez-Esquivel; Elisa Pose; Ramón Bataller;
Ann Hepatol. 2024;29:
Prevalence of fibrosis and steatosis determined by transient elastography and controlled attenuation parameter (Fibroscan®) in diabetic patients
Kevin S. Vázquez-Hernández; Andres Burak-Leipuner; Alfredo I. Servin-Caamaño; Javier A. Romero-Bermúdez; Laura E. Ceceña-Martínez; José L. Pérez-Hernández; María C. Castañeda-Aguilar; Fátima Higuera-de la Tijera;
Ann Hepatol. 2025;30 Supl 1:
Prevalence of high-risk metabolic dysfunction-associated fatty liver disease (MASH) according to the FAST® index in a group of diabetic patients
Kevin S. Vázquez-Hernández; Andres Burak-Leipuner; Alfredo I. Servin-Caamaño; Javier A. Romero-Bermúdez; Laura E. Ceceña-Martínez; José L. Pérez-Hernández; María C. Castañeda-Aguilar; Fátima Higuera-de la Tijera;
Ann Hepatol. 2025;30 Supl 1: